Annual report pursuant to Section 13 and 15(d)

Equity - Summary of the Company's RSU Activity (Details)

v3.24.3
Equity - Summary of the Company's RSU Activity (Details) - $ / shares
12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares outstanding at the beginning of the period (in shares) 651,892    
Granted (in shares) 584,127    
Vested (in shares) (420,154)    
Forfeited (in shares) (112,243)    
Non-vested shares outstanding at the end of the period (in shares) 703,622 651,892  
Weighted Average Grant Date Fair Value      
Non-vested shares outstanding at the beginning of the period (in dollars per share) $ 75.46    
Granted (in dollars per share) 82.61    
Vested (in dollars per share) 77.79    
Forfeited (in dollars per share) 77.63    
Non-vested shares outstanding at the end of the period (in dollars per share) $ 79.66 $ 75.46  
Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares outstanding at the beginning of the period (in shares) 481,134    
Granted (in shares) 393,311    
Vested (in shares) (351,104)    
Forfeited (in shares) (87,744)    
Non-vested shares outstanding at the end of the period (in shares) 435,597 481,134  
Weighted Average Grant Date Fair Value      
Granted (in dollars per share)   $ 70.38 $ 79.75
Performance Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares outstanding at the beginning of the period (in shares) 170,758    
Granted (in shares) 190,816    
Vested (in shares) (69,050)    
Forfeited (in shares) (24,499)    
Non-vested shares outstanding at the end of the period (in shares) 268,025 170,758